Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Hickenlooper introduces PREPARE Act to develop federal framework for cannabis legalization

Nearly 10 years after Colorado’s legalization of cannabis, U.S. Sen. John Hickenlooper announced his plan Thursday to introduce legislation that would provide a framework for the federal government to follow suit.

His so-called PREPARE Act would require the U.S. Attorney General to convene a “Commission on the Federal Regulation of Cannabis” should the federal government ever vote to legalize cannabis. According to a news release from Hickenlooper’s office, the commission’s role would be to make recommendations related to cannabis policy; it would not have the authority to institute any policies itself.

“This bill will provide lawmakers across the ideological spectrum the opportunity to engage on cannabis reform by creating a fair, honest, and publicly transparent process for the federal government to establish effective regulation to be enacted upon the termination of its 85-year prohibition of cannabis,” Hickenlooper’s office wrote in a summary of the bill.

In the bill summary, Hickenlooper’s office suggests that Colorado’s position as a state that has had a regulated cannabis market for a decade “should be leveraged to the largest extent possible in designing a federal regulatory framework.”

Related: Mexico Approaches October Court Deadline for Recreational Cannabis Framework

Top 5 CBD Oil Brands for 2022

Hickenlooper, who was serving as Colorado’s governor when the state Legislature voted to legalize cannabis in November 2012, established a task force to advise him on how to regulate the industry. According to the news release, the Commission of the Federal Regulation of Cannabis would be modeled after this task force.

According to the bill summary, the commission would be comprised of 24 members, including:

  • An individual who has been formerly incarcerated for a nonviolent cannabis-related crime appointed by the Senate Majority Leader.
  • An expert in substance abuse appointed by the Senate Minority Leader.
  • A medical cannabis patient or advocate appointed by the House of Representatives Majority Leader.
  • A medical professional with demonstrated research into the medical properties of cannabis appointed by the House Minority Leader.
  • A Department of Justice expert in the history of cannabis criminalization and its impact appointed by the Attorney General.
  • Members of other relevant offices, including the National Institutes of Health and the Bureau of Alcohol, Tobacco and Firearms.

Federal agency representatives from the DOJ as well as the departments of Education, Health, Commerce and Human Services would also be part of the commission, as well as cannabis industry representatives and individuals who have participated in the development of successful regulatory systems at the state level.

According to the release, the framework must include specific steps to address “the disproportionate impact cannabis prohibition has had on minority, low-income, and veteran communities.”

Top 5 CBD Oil Brands for 2022

The bill identifies a need to address issues such as the impact of cannabis criminalization on marginalized communities, lack of financial sector access for cannabis entrepreneurs, and lack of consistent regulations for cannabis product safety and use. Lack of access to cannabis-related medical research and training at publicly funded medical facilities is also underscored.

If passed, the PREPARE Act would go into immediate effect upon federal legalization of cannabis. (PREPARE stands for Preparing Regulators Effectively for a Post-Prohibition Adult Use Regulated Environment.)

Last month, President Joe Biden officially pardoned all prior federal offenses of simple cannabis possession and urged all U.S. governors to do the same.

Currently, cannabis is federally classified as a Schedule I Drug in the Controlled Substances Act. The Schedule I classification is used to identify substances with no accepted medical uses and a high abuse potential; other Schedule I drugs include heroin and ecstasy. The Biden administration also asked the attorney general and the secretary of health and human services to begin a review of cannabis’ current classification of a Schedule I drug in the Controlled Substances Act.

Now that the Biden administration has taken steps toward decriminalizing cannabis, Hickenlooper says, Colorado should prepare to lead the country in establishing guidelines for legalization.

“Colorado successfully pioneered marijuana legalization a decade ago, thanks in part to the Amendment 64 Task Force,” Hickenlooper said. “Federal legalization doesn’t need to start from scratch, and we should prepare for when it arrives.”

Hickenlooper introduces PREPARE Act to develop federal framework for cannabis legalization


About Cannin: Your Cannabis Stocks Resource

78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021. 

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +34% Gains in 2022
  • +56% Gains in 2021
  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.